Background: Acute kidney injury (AKI) is a common complication of the over 200 million noncardiac surgeries performed worldwide each year. We conducted a pre-specified substudy of the POISE-3 trial to determine whether a peri-operative hypotension-avoidance strategy versus a hypertension-avoidance strategy alters the risk of postoperative AKI (substudy protocol publication: PMID 35024154). Methods: This was a two-group, open-label, randomized trial of 7307 high-risk patients from 110 hospitals in 22 countries undergoing noncardiac surgery. Patients were ≥ 45 years old and took at least one antihypertensive medication. hypotension-avoidance strategy ... target intraopertive mean arterial pressure (MAP) ≥80 mmHg ... on day of surgery and for 2 days after, aim to hold renin-angiotensin-aldosterone system inhibitors ... stepwise use other long-term antihypertensive medications if SBP ≥130 mmHg hypertension-avoidance strategy ... target intraoperative MAP ≥60 mmHg ... continue all antihypertensive medications before and after surgery. The primary outcome was postoperative AKI, defined as an increase in serum creatinine concentration of either ≥26.5 μmol/L (≥0.3 mg/dL) within 48 hours of randomization or ≥50% within 7 days of randomization. Results: The hypotension-avoidance group (n=3654) vs. the hypertension-avoidance group (n=3653), ... used fewer antihypertensive medications ...........specifically, 6% vs. 38% of patients used an ACEi or ARB on the day of surgery, ..............................6% vs. 47% one day after surgery, ............................. 7% vs. 50% two days after surgery. ... spent less intraoperative time with a MAP < 80 mmHg (average 28% vs. 45% of the time) ... had no difference in mean SBP/DBP/MAP outside the operation (day of surgery and two days after surgery) ... had no difference in the risk of AKI ........... (15.1% vs. 14.4%; relative risk 1.05 [95% CI, 0.93 to 1.19]). Results were consistent with multiple alternate continuous and categorical definitions of AKI and in the subgroup with baseline chronic kidney disease. Conclusion: In this trial of patients undergoing noncardiac surgery, the risk of postoperative AKI did not differ between patients randomized to receive a hypotension-avoidance strategy versus a hypertension-avoidance strategy.. Trial registration: NCT03505723. Funding: Private Foundation Support, Government Support - Non-U.S.